| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 赛分科技有限公司（SepaxTechnologies,Inc.）于2002年在美国特拉华州成立，致力于开发和生产用于生物大分子等药物分离纯化的液相色谱材料和技术。历经二十年在色谱层析领域的深耕，赛分科技已发展成为一个集研发、生产和全球销售为一体的实业型企业，全球客户超5000家。公司主要产品为色谱层析介质、液相色谱柱，为全球生物制药企业提供从药品研发、临床前（Pre-IND）到临床Ⅰ、Ⅱ、Ⅲ期、生产以及质控全周期全流程分析色谱和工业纯化解决方案。为了更好地为中国客户提供产品和服务，赛分科技2009年实施中国发展战略，成立苏州赛分科技有限公司，落户、扎根于苏州工业园区。2018年2月建成二万六千平米的总部大楼，以满足客户需求为己任，专注产品研发、技术创新和工艺开发，深化与全球客户的战略合作。为满足高速发展的中国生物制药下游分离纯化需求，赛分科技于2017年在扬州高新技术产业开发区成立赛分科技扬州有限公司，注册资本金一亿元人民币，总投入超五亿元，建设三万平米厂房设施，专注色谱层析介质的生产。其中一期工程已于2020年12月投入使用，包括抗体、疫苗、胰岛素、重组蛋白以及小分子药物专用介质八条生产线。二期工程预计于2023年初开始建设，总产能将超二十万升，从而使赛分科技成为全球同行业中生产规模最大的企业之一，具有全球竞争力的现代化、规范化、规模化的高端制造企业。 | ||||||||||||||||||||||||
| Main Business | 研发和生产用于药物分析检测和分离纯化的液相色谱材料 | ||||||||||||||||||||||||
| Legal Representative | 黄学英 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 黄漫履 | ||||||||||||||||||||||||
| Solicitors | 北京海润天睿律师事务所 | ||||||||||||||||||||||||
| Auditors | 容诚会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 86-512-69369067 | ||||||||||||||||||||||||
| Fax No | 86-512-69369025 | ||||||||||||||||||||||||
| Website | www.sepax-tech.com.cn | ||||||||||||||||||||||||
| ir@sepax-tech.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 10/01/2025 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.140 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 2.720 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 0.818B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |